Clinical use of recombinant human hematopoietic growth factors (GM-CSF, IL-3, EPO) in patients with myelodysplastic syndrome.

Source:http://linkedlifedata.com/resource/pubmed/id/1845132

Download in:

View as

General Info

PMID
1845132